According to a new market report published by Lucintel, the future of the transfection reagent and equipment market looks promising with opportunities in biomedical research, protein production, and therapeutic delivery applications. The global transfection reagent and equipment market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are rising research activities related to cell science, surge in demand for synthetic genes, increasing prevalence of cancer, and advancement in transfection technologies.
To download report brochure, please go to https://www.lucintel.com/transfection-reagent-and-equipment-market.aspx and click "download brochure" tab from the menu
Transfection is a process of deliberately introducing genetic material such as DNA or RNA into eukaryotic cells to enable the production or expression of proteins. In this market, biomedical research, protein production, and therapeutic delivery are the major applications. Lucintel forecasts that biomedical research will remain the largest application segment over the forecast period due to increasing expenditure on research and development activities by pharmaceutical and biotechnology companies and growing cases of cancer.
Within this market, academic and research institutes will remain the largest end user segment over the forecast period due to increasing research activities related to gene expression, gene silencing studies, and analysis of recombinant proteins.
North America will remain the largest region over the forecast period due to increasing research activities related to bio-based drugs, surge in demand for protein therapeutics, and rising investment for development of biologics in the region.
Thermo Fisher Scientific, Promega, Roche, Qiagen, Polyplus-transfection, Bio-Rad Laboratories, Lonza, Sigma-Aldrich, Mirus Bio, and MaxCyte are among the major suppliers in the global transfection reagent and equipment market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global transfection reagent and equipment market by product, method, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Transfection Reagent and Equipment Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global transfection reagent and equipment market by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
Biochemical
Calcium Phosphate
Lipofection
Deae-Dextran
Dendrimers
Physical
Electroporation
Nucleofection
Other Methods
Viral Methods
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biomedical Research
Gene Expression Studies
Cancer Research
Transgenic Models
Protein Production
Therapeutic Delivery
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academics & Research Institutes
Pharmaceutical & Biotechnology Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.